Loading...
Pharmacological Treatments for Patients with Treatment-Resistant Depression
Over a third of patients with major depressive disorder (MDD) do not have an adequate response to first-line antidepressant treatments, i.e., they have treatment-resistant depression (TRD). These patients tend to have a more severe course of illness and are at an increased risk of suicide. Next step...
Na minha lista:
| Udgivet i: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7345023/ https://ncbi.nlm.nih.gov/pubmed/32512768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13060116 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|